scispace - formally typeset
A

Arati Sharma

Researcher at Pennsylvania State University

Publications -  64
Citations -  4300

Arati Sharma is an academic researcher from Pennsylvania State University. The author has contributed to research in topics: Melanoma & Cancer. The author has an hindex of 28, co-authored 63 publications receiving 3919 citations. Previous affiliations of Arati Sharma include Penn State Milton S. Hershey Medical Center & Penn State Cancer Institute.

Papers
More filters
Journal ArticleDOI

Deregulated Akt3 Activity Promotes Development of Malignant Melanoma

TL;DR: It is reported that selective activation of the Akt3 protein promotes cell survival and tumor development in 43 to 60% of nonfamilial melanomas and provides new therapeutic opportunities for patients in the advanced stages of this disease.
Journal ArticleDOI

Mutant V599EB-Raf regulates growth and vascular development of malignant melanoma tumors.

TL;DR: The mechanistic underpinnings by which mutant (V599E)B-RAF promotes melanoma development are identified and the effectiveness of targeting this protein to inhibit melanoma tumor growth is shown.
Journal ArticleDOI

Transiently entrapped circulating tumor cells interact with neutrophils to facilitate lung metastasis development.

TL;DR: A novel model has been developed in this study showing that neutrophils regulate lung metastasis development through physical interaction and anchoring of circulating tumor cells to endothelium, and targeting IL-8 in melanoma cells has the potential to decrease metastases development by disrupting interaction with neutrophil.
Journal Article

Loss of PTEN Promotes Tumor Development in Malignant Melanoma

TL;DR: Loss of PTEN reduces apoptosis and promotes cell survival, thereby favoring melanoma tumor formation and providing an etiological basis for PTEN loss during the genesis of sporadic melanomas.
Journal ArticleDOI

Calcium Phosphate Nanocomposite Particles for In Vitro Imaging and Encapsulated Chemotherapeutic Drug Delivery to Cancer Cells

TL;DR: Calcium phosphate nanocomposite particles (CPNPs) are reported on that encapsulate both fluorophores and chemotherapeutics, are colloidally stable in physiological solution for an extended time at 37 degrees C and can efficaciously deliver hydrophobic antineoplastic agents in several cell model systems.